During the past decade, APG Research, LLC conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 8 clinical trials were completed, i.e. on average, 27.6% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 6 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "APG Research, LLC" #1 sponsor was "Janssen Research & Development, LLC" with 6 trials, followed by "Emalex Biosciences Inc." with 3 trials sponsored, "Sunovion" with 3 trials sponsored, "Supernus Pharmaceuticals, Inc." with 3 trials sponsored and "Biohaven Pharmaceuticals, Inc." with 3 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "APG Research, LLC" #1 collaborator was "Innovis LLC" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "APG Research, LLC" are "Depressive Disorder, Major" (5 trials), "Attention Deficit Hyperactivity Disorder (ADHD)" (3 trials), "ADHD" (2 trials), "Autism Spectrum Disorder" (2 trials) and "Bipolar Disorder" (2 trials). Many other conditions were trialed in "APG Research, LLC" in a lesser frequency.

Most popular intervention types in "APG Research, LLC" are "Drug" (27 trials), "Other" (3 trials), "Device" (1 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (18 trials), "400mg SPN-812" (2 trials), "Aticaprant" (2 trials), "Ecopipam" (2 trials) and "SPD489" (2 trials). Other intervention names were less common.

The vast majority of trials in "APG Research, LLC" are 31 trials for "All" genders.

Currently, there are NaN active trials in "APG Research, LLC". undefined are not yet recruiting, 14 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 13 completed trials in APG Research, LLC, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in APG Research, LLC, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 3 trials that are defined as “Not Applicable".